In This Section

Cancer Molecular Imaging and Theranostics Task Force

The Cancer Molecular Imaging and Theranostics (CMIT) Task Force is committed to accelerating the development, expansion, and application of molecular imaging and theranostic strategies to conquer cancer through:

  • Research
  • Education
  • Communication and scholarly discussion
  • Cross-disciplinary collaboration

CMIT fosters research in novel molecular targeting; furthers understanding of biological mechanisms that drive clinical response; and provides a forum for scholarly discussion and dissemination of research findings on molecular imaging, diagnostics, biomarkers, and radiopharmaceutical therapy among laboratory, translational, and clinical researchers.